Form 6K Artrya Ltd For: 16 June
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Artrya Ltd (AYA)
Artrya Ltd stock price live, this page displays ASX AYA stock exchange data. View the AYA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Artrya Ltd real time stock price chart below.
What Is the Artrya Ltd Stock Price Today?
The Artrya Ltd stock price today is 3.14.
What Is the Stock Symbol for Artrya Ltd?
The stock symbol for Artrya Ltd is "AYA."
What Stock Exchange Does Artrya Ltd Trade On?
Artrya Ltd is listed and trades on the Sydney stock exchange.
Is Artrya Ltd a Good Stock to Buy?
Determining whether Artrya Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AYA quote. (ISIN: AU0000182412)
What Is the Artrya Ltd Stock Price Today?
The Artrya Ltd stock price today is 3.14.
What Is the Stock Symbol for Artrya Ltd?
The stock symbol for Artrya Ltd is "AYA."
What Stock Exchange Does Artrya Ltd Trade On?
Artrya Ltd is listed and trades on the Sydney stock exchange.
Is Artrya Ltd a Good Stock to Buy?
Determining whether Artrya Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AYA quote. (ISIN: AU0000182412)
Sydney
Currency in AUD
3.14
-0.14(-4.13%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.10
3.28
52 wk Range
2.09
6.49
AYA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.103.28
52 wk Range
2.096.49
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AYA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
5.99
Upside
+90.76%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Form 6K Artrya Ltd For: 20 May- Investing.com
Form 6K Artrya Ltd For: 12 June- Investing.com
Form 6K Artrya Ltd For: 14 May- Investing.com
Form 6K Artrya Ltd For: 4 June- Investing.com
- Form 6K Artrya Ltd For: 16 June
- Investing.com
- Form 6K Artrya Ltd For: 12 June
- Investing.com
- Form 6K Artrya Ltd For: 4 June
- Investing.com
Form 6K Artrya Ltd For: 2 June- Investing.com
Form 6K Artrya Ltd For: 1 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 5.99
(+90.76% Upside)
Artrya Ltd Earnings Call Summary for Q2/2026
- Artrya Ltd reported Q2 2026 customer receipts of $60,000, raised AUD 80 million, and maintained AUD 76.5 million in cash reserves despite a 1.27% stock price decline to $3.53.
- The company successfully converted three U.S. foundation partners into full commercial customers and established an on-ground customer success team to strengthen its American market presence.
- Artrya launched the Salix Coronary Plaque module and is targeting FDA clearance for its Flow module by June 2026, aiming to capture a share of 400,000 annual CCTA scans in the U.S.
- Management expects to fully integrate U.S. customers and increase foundation customer engagement by FY27, with SAPPHIRE partners inclusion anticipated by FY28.
- Operating outflows decreased to $5.4 million from $6.1 million in the previous quarter, reflecting improved operational efficiency as the company expands.
Last Updated: 02/02/2026, 08:48 AM
Read Full TranscriptEarnings
Latest Release
Aug 19, 2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
14K / --
Compare AYA to Peers and Sector
Metrics to compare | AYA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAYAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −21.2x | −2.7x | −0.4x | |
PEG Ratio | −4.72 | 0.00 | 0.00 | |
Price/Book | 6.8x | 3.4x | 2.6x | |
Price / LTM Sales | 19,031.8x | 4.5x | 3.0x | |
Upside (Analyst Target) | 83.5% | 50.7% | 54.8% | |
Fair Value Upside | Unlock | −21.1% | 8.1% | Unlock |
Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. It offers Salix, a suite of cloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. The company was incorporated in 2018 and is based in West Perth, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Artrya (AYA) Stock Price Today?
The Artrya stock price today is 3.14 AUD.
What Stock Exchange Does Artrya Trade On?
Artrya is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Artrya?
The stock symbol for Artrya is "AYA."
What Is the Artrya Market Cap?
As of today, Artrya market cap is 532.89M AUD.
What Is Artrya's Earnings Per Share (TTM)?
The Artrya EPS (TTM) is -0.17.
From a Technical Analysis Perspective, Is AYA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Artrya Stock Split?
Artrya has split 0 times.
What is the current trading status of Artrya (AYA)?
As of Sep 14, 2026, Artrya (AYA) is trading at a price of 3.14 AUD, with a previous close of 3.27 AUD. The stock has fluctuated within a day range of 3.10 AUD to 3.28 AUD, while its 52-week range spans from 2.09 AUD to 6.49 AUD.
What Is Artrya (AYA) Price Target According to Analysts?
The average 12-month price target for Artrya is 5.99 AUD, with a high estimate of 6.07 AUD and a low estimate of 5.9 AUD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +90.76% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.